Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Multiomic approaches to identify at-risk patients with thoracic aortic aneurysms
FY 2024-25
Summary
The aorta is the largest artery carrying blood out of the heart. In thoracic aortic aneurysm disease (TAAD), part of the aorta enlarges, increasing the risk of acute type A aortic dissection (ATAD), a life-threatening tear in the aortic wall. Elective (planned) surgery to replace the enlarged section prevents ATAD but still carries risks of stroke and death; thus, it is reserved for high-ATAD-risk patients. Identifying who is at high risk is challenging as guidelines rely on the aortic size, yet half of ATAD cases occur in aneurysms below the threshold for surgery. Our project looks at biomarkers, measurable molecules (proteins, in our case) that could signal ATAD risk. Using mass spectrometry (MS) in human aorta samples, we identified three proteins involved in the structure, growth and survival of cells in arteries: CCN5, LMOD1, and MFAP4. These proteins showed differing levels in patients with TAAD vs. ATAD, and between sexes, suggesting potential as ATAD risk indicators.My specific aims: 1.
Working with the Canadian Thoracic Aortic Collaborative TiTAN study, I have unprecedented access to over 1,000 well annotated blood samples from borderline TAAD patients randomized to surgery or watchful waiting. I will compare CCN5, LMOD1, and MFAP4 blood levels in patients with non-growing aneurysms vs. those needing surgery due to ATAD or aneurysm growth. 2.
I will compare our results to the UK Biobank database with ;100,000 patient records. Using machine learning, data from patient records, MS, and our previous research will be systematically integrated to inform us on traits linked to ATAD risk. 3.
I will knock out (inactivate) these proteins in smooth muscle cells cultured on a dish to show their impact on cells ability to move, stick, and reproduce.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
529956
Name
Hu Mostin AIyu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Multiomic approaches to identify at-risk patients with thoracic aortic aneurysms
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aortic Dissection; Biomarker; Proteomics; Thoracic Aortic Aneurysm
Abstract
The aorta is the largest artery carrying blood out of the heart. In thoracic aortic aneurysm disease (TAAD), part of the aorta enlarges, increasing the risk of acute type A aortic dissection (ATAD), a life-threatening tear in the aortic wall. Elective (planned) surgery to replace the enlarged section prevents ATAD but still carries risks of stroke and death; thus, it is reserved for high-ATAD-risk patients. Identifying who is at high risk is challenging as guidelines rely on the aortic size, yet half of ATAD cases occur in aneurysms below the threshold for surgery. Our project looks at biomarkers, measurable molecules (proteins, in our case) that could signal ATAD risk. Using mass spectrometry (MS) in human aorta samples, we identified three proteins involved in the structure, growth and survival of cells in arteries: CCN5, LMOD1, and MFAP4. These proteins showed differing levels in patients with TAAD vs. ATAD, and between sexes, suggesting potential as ATAD risk indicators.My specific aims: 1.
Working with the Canadian Thoracic Aortic Collaborative TiTAN study, I have unprecedented access to over 1,000 well annotated blood samples from borderline TAAD patients randomized to surgery or watchful waiting. I will compare CCN5, LMOD1, and MFAP4 blood levels in patients with non-growing aneurysms vs. those needing surgery due to ATAD or aneurysm growth. 2.
I will compare our results to the UK Biobank database with ;100,000 patient records. Using machine learning, data from patient records, MS, and our previous research will be systematically integrated to inform us on traits linked to ATAD risk. 3.
I will knock out (inactivate) these proteins in smooth muscle cells cultured on a dish to show their impact on cells ability to move, stick, and reproduce.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hu, Mostin AIyu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~